Skip to contentA
Accendra Health Inc
A
ACHAccendra Health Inc Q3 2022 · 10-Q
Revenue$2.50B$2.50B−0.2% vs Q3 2021 Net Income$12.50M$12.50M−71.7% vs Q3 2021 EPS Diluted$0.16$0.16−72.4% vs Q3 2021 Gross Profit$513,279,000+56.1% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Accendra Health Inc · CIK 75252 · Engraved from SEC EDGAR
Operating Cash Flowderived$68,521,000+11.5% Free Cash Flowderived$21,482,000−56.7% Margins · derivedGross margin20.6%+7.4 pt vs Q3 2021
Operating margin2.4%−0.1 pt vs Q3 2021
Net margin0.5%−1.3 pt vs Q3 2021
ended Sep 30, 2022 · filed Nov 2, 2022 · 33 d after period end